CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Biogaia B - BIOGb CFD

    103.1
    2.09%
    3.2
    Low: 103.1
    High: 105.5
    Market Trading Hours* (UTC) Opens on Monday at 08:00

    Mon - Fri: 08:00 - 16:25

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 3.2
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021945 %
    Charges from full value of position ($-4.17)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021945%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000277 %
    Charges from full value of position ($-0.05)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000277%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency SEK
    Margin 5%
    Stock exchange Sweden
    Commission on trade 0%

    *Information provided by Capital.com

    Biogaia AB ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 105.3
    Open* 105.2
    1-Year Change* 25.69%
    Day's Range* 103.1 - 105.5
    52 wk Range 81.03-119.40
    Average Volume (10 days) 128.16K
    Average Volume (3 months) 1.86M
    Market Cap 10.55B
    P/E Ratio 25.05
    Shares Outstanding 100.98M
    Revenue 1.27B
    EPS 4.33
    Dividend (Yield %) 2.67281
    Beta 0.70
    Next Earnings Date Feb 7, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 105.3 1.5 1.45% 103.8 105.7 100.7
    Nov 29, 2023 104.3 0.9 0.87% 103.4 104.8 103.4
    Nov 28, 2023 105.2 0.9 0.86% 104.3 105.9 102.4
    Nov 27, 2023 105.0 -1.0 -0.94% 106.0 106.6 103.5
    Nov 24, 2023 106.6 -1.2 -1.11% 107.8 108.4 105.7
    Nov 23, 2023 108.1 0.2 0.19% 107.9 108.8 107.1
    Nov 22, 2023 107.9 3.4 3.25% 104.5 107.9 103.8
    Nov 21, 2023 103.9 2.0 1.96% 101.9 104.1 101.2
    Nov 20, 2023 102.0 2.3 2.31% 99.7 102.3 97.7
    Nov 17, 2023 98.1 -3.1 -3.06% 101.2 101.9 98.0
    Nov 16, 2023 101.3 -1.0 -0.98% 102.3 102.6 99.9
    Nov 15, 2023 103.2 -1.0 -0.96% 104.2 104.8 99.3
    Nov 14, 2023 103.2 -2.1 -1.99% 105.3 106.8 103.1
    Nov 13, 2023 105.7 2.1 2.03% 103.6 106.0 103.4
    Nov 10, 2023 104.1 0.2 0.19% 103.9 104.6 102.6
    Nov 9, 2023 102.8 -0.2 -0.19% 103.0 105.3 102.8
    Nov 8, 2023 104.1 2.2 2.16% 101.9 105.1 101.3
    Nov 7, 2023 101.3 2.8 2.84% 98.5 101.7 96.9
    Nov 6, 2023 99.0 -2.8 -2.75% 101.8 103.1 98.0
    Nov 3, 2023 101.9 0.0 0.00% 101.9 103.1 100.0

    Biogaia B Events

    Time (UTC) Country Event
    Wednesday, February 7, 2024

    Time (UTC)

    10:59

    Country

    SE

    Event

    Q4 2023 Biogaia AB Earnings Release
    Q4 2023 Biogaia AB Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1103.96 785.11 747.077 768.347 741.87
    Revenue 1103.96 785.11 747.077 768.347 741.87
    Cost of Revenue, Total 302.028 202.161 200.159 204.349 185.956
    Gross Profit 801.929 582.949 546.918 563.998 555.914
    Total Operating Expense 742.498 531.373 518.927 525.836 464.511
    Selling/General/Admin. Expenses, Total 358.26 233.221 196.289 207.058 179.783
    Research & Development 103.977 102.865 102.84 103.164 98.776
    Depreciation / Amortization 5.184 4.364 3.296 3.765 1.945
    Interest Expense (Income) - Net Operating -26.792 -11.506 0 -6.504
    Operating Income 361.459 253.737 228.15 242.511 277.359
    Interest Income (Expense), Net Non-Operating 86.154 -1.025 -0.567 -0.252 0.641
    Other, Net -0.405
    Net Income Before Taxes 447.613 252.712 227.583 242.259 277.595
    Net Income After Taxes 373.773 196.273 179.73 187.258 214.233
    Minority Interest 0 0 0 0.089 0.657
    Net Income Before Extra. Items 373.773 196.273 179.73 187.347 214.89
    Total Extraordinary Items
    Net Income 373.773 196.273 179.73 187.347 214.89
    Income Available to Common Excl. Extra. Items 373.773 196.273 179.73 187.347 214.89
    Income Available to Common Incl. Extra. Items 373.773 196.273 179.73 187.347 214.89
    Diluted Net Income 373.773 196.273 179.73 187.347 214.89
    Diluted Weighted Average Shares 100.982 100.963 89.2403 86.68 86.68
    Diluted EPS Excluding Extraordinary Items 3.70138 1.944 2.014 2.16136 2.47912
    Dividends per Share - Common Stock Primary Issue 2.9 1.452 1.364 1.6 2
    Diluted Normalized EPS 3.74232 2.07652 2.014 2.16136 2.47912
    Other Operating Expenses, Total 0 0.366 16.343 7.5 4.555
    Unusual Expense (Income) -0.159 -0.098
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total revenue 317.694 315.217 365.821 274.283 257.733
    Revenue 317.694 315.217 365.821 274.283 257.733
    Cost of Revenue, Total 81.847 88.779 103.309 66.291 71.952
    Gross Profit 235.847 226.438 262.512 207.992 185.781
    Total Operating Expense 198.156 220.18 217.823 203.157 163.998
    Selling/General/Admin. Expenses, Total 96.002 101.045 97.887 101.961 84.578
    Research & Development 20.63 38.816 18.684 31.431 22.557
    Other Operating Expenses, Total -0.323 -8.46 -2.057 3.474 -15.089
    Operating Income 119.538 95.037 147.998 71.126 93.735
    Interest Income (Expense), Net Non-Operating 8.484 7.023 2.563 81.323 5.066
    Net Income Before Taxes 128.022 102.06 150.561 152.449 98.801
    Net Income After Taxes 101.501 80.547 115.945 139.428 79.503
    Minority Interest 0 0 0 0 0
    Net Income Before Extra. Items 101.501 80.547 115.945 139.428 79.503
    Net Income 101.501 80.547 115.945 139.428 79.503
    Income Available to Common Excl. Extra. Items 101.501 80.547 115.945 139.428 79.503
    Income Available to Common Incl. Extra. Items 101.501 80.547 115.945 139.428 79.503
    Diluted Net Income 101.501 80.547 115.945 139.428 79.503
    Diluted Weighted Average Shares 100.982 100.982 100.982 100.982 100.982
    Diluted EPS Excluding Extraordinary Items 1.00514 0.79764 1.14817 1.38072 0.7873
    Dividends per Share - Common Stock Primary Issue 0 0 0 2.9 0
    Diluted Normalized EPS 1.00514 0.80747 1.14817 1.39612 0.7873
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1797.48 1752.08 1689.58 452.438 494.415
    Cash and Short Term Investments 1488.37 1484.68 1467.88 218.814 289.794
    Cash & Equivalents 1488.37 1484.68 1467.88 213.831 284.962
    Short Term Investments 0 4.983 4.832
    Total Receivables, Net 149.455 148.53 143.196 156.316 154.819
    Accounts Receivable - Trade, Net 131.054 128.152 101.658 129.763 142.009
    Total Inventory 142.838 102.737 72.277 68.445 44.213
    Prepaid Expenses 1.872 0 1.735 1.731 1.477
    Other Current Assets, Total 14.95 16.13 4.486 7.132 4.112
    Total Assets 2213.97 2128.05 1913.28 665.9 659.973
    Property/Plant/Equipment, Total - Net 157.725 153.635 162.765 149.042 105.935
    Property/Plant/Equipment, Total - Gross 301.359 275.996 256.218 218.949 166.773
    Accumulated Depreciation, Total -143.634 -122.361 -93.453 -69.909 -60.84
    Intangibles, Net 46.075 48.086 50.322 52.558 45.85
    Long Term Investments 25.843 22.272 0.039 0.044 0.043
    Other Long Term Assets, Total 15.325 2.757 5.279 6.518 8.43
    Total Current Liabilities 164.991 126.954 135.062 124.8 145.173
    Accounts Payable 32.05 42.313 48.046 28.491 34.009
    Accrued Expenses 77.945 56.399 48.723 53.913 57.349
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 43.896 19.342 30.093 34.83 53.815
    Total Liabilities 241.55 250.689 167.039 158.028 154.991
    Total Long Term Debt 0 10.4 20.7 17.254 0
    Deferred Income Tax 12.552 14.24 11.312 10.339 6.679
    Minority Interest 0.002 0.002 0.002 0.002 3.139
    Total Equity 1972.42 1877.36 1746.24 507.872 504.982
    Common Stock 20.196 20.196 20.196 17.336 17.336
    Additional Paid-In Capital 1153.79 1154.01 1149.48 21.831 43.662
    Retained Earnings (Accumulated Deficit) 798.426 703.161 576.564 468.705 443.984
    Total Liabilities & Shareholders’ Equity 2213.97 2128.05 1913.28 665.9 659.973
    Total Common Shares Outstanding 100.982 98.0196 98.0196 83.7196 83.7196
    Goodwill, Net 171.517 149.227 5.3 5.3 5.3
    Current Port. of LT Debt/Capital Leases 11.1 8.9 8.2 7.566
    Capital Lease Obligations 10.4 20.7 17.254
    Other Liabilities, Total 64.005 99.093 -0.037 5.633
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1834.53 1718.72 1922.49 1797.48 1728.3
    Cash and Short Term Investments 1452.53 1369.57 1580.82 1488.37 1402.41
    Cash & Equivalents 1452.53 1369.57 1580.82 1488.37 1402.41
    Other Current Assets, Total 382.002 349.159 341.664 16.841 325.89
    Total Assets 2304.25 2157.08 2324 2213.97 2161.37
    Property/Plant/Equipment, Total - Net 208.776 178.091 152.293 157.725 163.321
    Goodwill, Net 177.906 178.059 170.084 171.517 182.343
    Intangibles, Net 46.172 46.154 46.128 46.075 46.409
    Long Term Investments 28.065 28.065 25.842 25.843 25.845
    Other Long Term Assets, Total 8.804 7.982 7.17 15.325 15.154
    Total Current Liabilities 217.488 217.764 186.275 164.991 173.367
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 217.488 217.764 186.275 43.896 173.367
    Total Liabilities 318.982 273.271 237.137 241.55 312.53
    Total Long Term Debt 0 0 0 0 0
    Deferred Income Tax 13.274 13.29 12.532 12.552 14.166
    Minority Interest 0.002 0.002 0.002 0.002 0.002
    Other Liabilities, Total 88.218 42.215 38.328 64.005 124.995
    Total Equity 1985.27 1883.81 2086.87 1972.42 1848.84
    Other Equity, Total 1985.27 1883.81 2086.87 1972.42 1848.84
    Total Liabilities & Shareholders’ Equity 2304.25 2157.08 2324 2213.97 2161.37
    Total Common Shares Outstanding 100.982 100.982 100.982 100.982 100.982
    Total Receivables, Net 149.436
    Accounts Receivable - Trade, Net 130.703
    Total Inventory 142.838
    Accounts Payable 32.05
    Accrued Expenses 77.945
    Current Port. of LT Debt/Capital Leases 11.1
    Capital Lease Obligations
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 361.459 253.737 228.15 242.511 277.359
    Cash From Operating Activities 318.943 221.875 221.256 147.855 183.12
    Cash From Operating Activities 23.89 27.241 20.53 15.593 7.546
    Non-Cash Items -9.103 0.047 -3.709 3.075 0.591
    Cash Taxes Paid 54.91 55.934 72.092 72.292 52.408
    Cash Interest Paid 0.694 0.401
    Changes in Working Capital -57.303 -59.15 -23.715 -113.324 -102.376
    Cash From Investing Activities -18.141 -126.967 -16.075 -39.024 -47.301
    Capital Expenditures -17.916 -6.379 -16.075 -39.024 -13.454
    Other Investing Cash Flow Items, Total -0.225 -120.588 0 -33.847
    Cash From Financing Activities -313.588 -81.846 1051.4 -181.09 -158.728
    Total Cash Dividends Paid -301.331 -68.87 -65.012 -173.365 -156.028
    Issuance (Retirement) of Stock, Net -0.214 4.525 1126.84
    Foreign Exchange Effects 16.472 3.735 -2.525 1.128 2.015
    Net Change in Cash 3.686 16.797 1254.05 -71.131 -20.894
    Financing Cash Flow Items -2.9 -2.8 -2.8 -3.2 -2.7
    Issuance (Retirement) of Debt, Net -9.143 -14.701 -7.632 -4.525
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 147.998 361.459 290.333 196.598 95.295
    Cash From Operating Activities 98.434 318.943 227.624 180.355 93.065
    Cash From Operating Activities 6.519 23.89 17.25 12.131 6.049
    Non-Cash Items -0.044 -9.103 -12.048 -12.63 -1.136
    Cash Taxes Paid 34.995 54.91 56.67 35.943 17.512
    Changes in Working Capital -56.039 -57.303 -67.911 -15.744 -7.143
    Cash From Investing Activities -1.332 -18.141 -18.433 -13.896 -5.081
    Capital Expenditures -1.279 -17.916 -18.433 -13.896 -5.081
    Cash From Financing Activities -3.36 -313.588 -310.977 -305.541 -2.211
    Financing Cash Flow Items 0 -2.9 -2.9 0 0
    Total Cash Dividends Paid 0 -301.331 -301.331 -301.331 0
    Issuance (Retirement) of Stock, Net -0.417 -0.214 -0.206 -0.206 -0.206
    Issuance (Retirement) of Debt, Net -2.943 -9.143 -6.54 -4.004 -2.005
    Foreign Exchange Effects -1.286 16.472 19.515 10.746 1.24
    Net Change in Cash 92.456 3.686 -82.271 -128.336 87.013
    Other Investing Cash Flow Items, Total -0.053 -0.225 0 0 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    EQT Partners AB Private Equity 11.4769 11164630 0 2022-09-30 LOW
    Fjärde AP-Fonden Pension Fund 8.2957 8070000 0 2022-09-30 LOW
    Premier Asset Management Ltd Investment Advisor/Hedge Fund 5.19 5048743 -1166440 2023-05-29 LOW
    TIN Fonder Investment Advisor 3.2321 3144175 0 2022-09-30 LOW
    Cargill, Inc. Corporation 3.0839 3000000 0 2022-09-30
    Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 2.7468 2672087 -138200 2022-09-30 LOW
    Tredje AP Fonden Pension Fund 2.5902 2519716 210171 2022-09-30 MED
    AMF Tjänstepension AB Pension Fund 2.3396 2275985 0 2022-09-30 LOW
    Juno Investment Partners Investment Advisor 2.0324 1977135 121945 2022-09-30 LOW
    Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 1.4538 1414218 4267 2023-09-30 LOW
    Allianz Global Investors GmbH Investment Advisor 1.4276 1388739 18771 2023-08-31 LOW
    Lansförsäkringar Fondförvaltning AB Investment Advisor 1.2166 1183467 1071 2023-08-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.1643 1132648 2634 2023-09-30 LOW
    Nordea Funds Oy Investment Advisor 0.9951 968065 0 2023-09-30 LOW
    Montanaro Asset Management Limited Investment Advisor 0.8966 872200 0 2023-09-30 LOW
    SEB Investment Management AB Investment Advisor 0.5441 529253 4724 2023-09-30 LOW
    Annwall & Rothschild Investment AB Corporation 0.514 500000 0 2022-09-30 LOW
    Rainier Investment Management, LLC Investment Advisor 0.4856 472413 53813 2023-07-31 MED
    Florida State Board of Administration Pension Fund 0.4633 450693 -112542 2022-09-30 LOW
    Union Investment Privatfonds GmbH Investment Advisor 0.4597 447173 142173 2022-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Biogaia Company profile

    About BioGaia AB

    Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, BioGaia AB revenues increased 5% to SEK785.1M. Net income increased 9% to SEK196.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other operating expenses/operating incom decrease from SEK17.4M (expense) to SEK11.2M (income). Dividend per share increased from SEK6.82 to SEK7.26.

    Industry: Biopharmaceuticals

    Kungsbroplan 3
    STOCKHOLM
    STOCKHOLM 112 27
    SE

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    BTC/USD

    38,734.50 Price
    +2.440% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    74.50 Price
    -1.560% 1D Chg, %
    Long position overnight fee -0.0136%
    Short position overnight fee -0.0083%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    XRP/USD

    0.62 Price
    +0.840% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    US100

    16,001.20 Price
    +0.470% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading